Kazia Therapeutics | 20-F: FY2024 Annual Report
Kazia Therapeutics Secures Nasdaq Compliance
Express News | Kazia Therapeutics -Got Letter From Nasdaq Informing Co Has Regained Compliance With Minimum Bid Price Requirement for Continued Listing
Kazia Therapeutics Management to Meet With Maxim
Express News | Kazia Therapeutics Ltd - Full Data From Paxalisib Arm Expected Later This Year
Kazia Therapeutics Announces Granting of Type C Meeting With FDA to Discuss Potential Next Steps for Paxalisib in the Treatment of Newly Diagnosed Glioblastoma Multiforme
with the color comment... hey, you can add target to the list too
that mustache 
far008 : $Vast Renewables (VSTE.US)$ has no short shares. we should see an uptick
103822628 : Sorry , unusual volume ticks means wat?
Stock_Drift OP 103822628 : Look at the volume. It’s unusual